Insider

P&G keeps profit outlook despite higher raw material costs

Procter & Gamble's sales rose 4% to $23.3 billion in the first quarter of fiscal 2027, and earnings per share rose 1% to $1.97. The company kept its outlook for organic sales and earnings per share growth, though it expects higher raw material costs.

Verified against 4 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
Aisle of a well-stocked retail store with many products
Photo by Nathan Cima on Unsplash
$23.3 billion
Quarterly sales
4%
Organic sales growth
$1.97
Earnings per share

Key points

  • Organic sales, which exclude currency effects, acquisitions and divestitures, also rose 4%.
  • Gross margin fell 160 basis points.
  • P&G expects higher raw material, energy and transportation costs to cost it about $1.4 billion after tax.

Volumes drive sales growth

Organic sales, which exclude currency effects, acquisitions and divestitures, also rose 4%. Higher volumes added two percentage points, and a more favorable product mix added one.

According to the quarterly report, revenue was $23.3 billion, compared with $22.4 billion a year earlier. Adjusted earnings per share rose 1% to $2.00 and were unchanged excluding currency effects.

Revenue by quarter, $B

21.9Q2 '2526.2%19.8Q3 '2523%20.9Q4 '25*20.8%22.4Q1 '2626.2%22.2Q2 '2624.2%21.2Q3 '2621.5%21.2Q4 '26*18.6%23.3Q1 '2725.5%
Bottom row: operating margin (operating income divided by revenue). Q4 = fiscal year minus the three quarters reported on their own. Revenue as the company tagged it in its SEC filings (XBRL). Guidance is the company's own, not our forecast.

Sector context: 18 covered companies in Consumer Staples reported a median revenue change of +5.4% YoY in their latest filings.

Why the margin narrowed

Gross margin fell 160 basis points. The company attributes this to higher raw material costs and product reinvestments, partly offset by productivity savings.

P&G updated its outlook for all-in sales growth to a range of 2% to 4%, reflecting the purchase of Thorne, a vitamin and supplement brand. The $3.9 billion all-cash deal closed on October 1.

The company left unchanged its outlook for organic growth of 1% to 3% and adjusted earnings per share of $6.89 to $7.11.

Costs are the main pressure

P&G expects higher raw material, energy and transportation costs to cost it about $1.4 billion after tax. Together with other factors, this amounts to $0.79 per share, an 11% drag on adjusted earnings per share growth.

The company's outlook does not include a sharp rise in raw material costs, significant currency weakness or significant tariff changes.

What to watch

The next quarterly report will show whether gross margin keeps falling and how much Thorne adds to sales. Its results will be included starting with the quarter ending December 31, 2026.

Original sources

  1. 8-K EX-99.1 filing, October 22, 2026October 22, 2026SHA-256 of our archived copy 1c45f1666848…
  2. 8-K EX-99.1 filing, October 22, 2026October 22, 2026SHA-256 of our archived copy dc7bbd077672…
  3. 10-Q risk factors compared with the 10-Q filing, April 24, 2026October 22, 2026SHA-256 of our archived copy c38bd831723a…
  4. financial data (XBRL)October 22, 2026SHA-256 of our archived copy 5bbc6d15eb46…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards